The art and science of chemical synthesis are at the core of pharmaceutical innovation. Developing new drugs involves intricate multi-step processes where the selection and quality of chemical intermediates play a crucial role. One such intermediate gaining attention for its utility in complex synthesis is (±)-BAY-1251152, identified by CAS number 1610358-53-6. This compound serves as a valuable building block, enabling chemists to construct targeted molecular structures efficiently.

Understanding the Function of (±)-BAY-1251152

(±)-BAY-1251152 is classified as a pharmaceutical intermediate. This means it's not the final drug product but a key precursor synthesized along the pathway to an API. Its specific chemical structure and reactivity make it suitable for particular transformations, allowing for the introduction of necessary functional groups or the extension of molecular chains. The precise role of such intermediates is often tied to the specific therapeutic target or drug class being developed, but their availability in high purity is universally critical for reproducible and scalable synthesis.

Key Technical Specifications for Synthesis Planning

When incorporating an intermediate like (±)-BAY-1251152 into a synthesis plan, chemists rely on detailed technical data. The predicted boiling point of 494.2±55.0 °C and density of 1.36±0.1 g/cm³ provide crucial insights into the compound's physical behavior. This information aids in designing reaction conditions, purification methods (such as distillation or crystallization), and handling procedures. Manufacturers who consistently meet these specified parameters are invaluable partners for R&D teams.

Sourcing Strategies: Why a Reliable Manufacturer Matters

For procurement managers and research scientists, sourcing chemical intermediates involves more than just finding the lowest price. A reliable manufacturer ensures:

  • Consistent Purity: Batch-to-batch consistency is vital for predictable reaction outcomes and regulatory compliance.
  • Scalability: The ability to supply intermediates in varying quantities, from lab-scale to pilot-plant and commercial production, is essential. This is why suppliers often offer diverse packaging options (e.g., 100 mg to 10 g).
  • Timely Delivery: Delays in intermediate supply can halt critical synthesis projects. A manufacturer with efficient global shipping capabilities (e.g., utilizing DHL, FedEx, UPS) is key.
  • Technical Support: Access to technical data and responsive customer service can significantly ease the integration of new intermediates into existing workflows.

When seeking to buy (±)-BAY-1251152, engaging with established manufacturers, particularly those based in regions like China known for their chemical production expertise, can offer a competitive advantage. A straightforward inquiry process, often with a rapid response time for quotations (typically within 12 hours), facilitates efficient decision-making.

Conclusion

The successful synthesis of modern pharmaceuticals relies on the quality and availability of key intermediates such as (±)-BAY-1251152 (CAS 1610358-53-6). By understanding the technical specifications and prioritizing partnerships with reputable manufacturers and suppliers, pharmaceutical companies can optimize their chemical synthesis processes, accelerate drug development timelines, and ensure the consistent production of high-quality APIs. The strategic sourcing of such materials is a cornerstone of innovation in the pharmaceutical sector.